Results 251 to 260 of about 564,053 (333)
This study presents a binary tumor‐microenvironment‐on‐a‐chip (T‐MOC) system incorporating multicellular tumor spheroids (MCTs) as an alternative preclinical platform to evaluate the efficacy of anticancer natural products. The T‐MOC model reproduces in vivo drug delivery barriers and physiological conditions, enabling morphological analysis to predict
Youngwon Kim+7 more
wiley +1 more source
Anticoagulant regimens for different therapeutic plasma exchange modes. [PDF]
Yao R+12 more
europepmc +1 more source
Naturally derived biomembrane nanostructures by mimicking evolutionarily optimized biological architectures could effectively suppress tumor growth and have emerged as a compelling strategy in translational biomedicine. This review provides a systematic overview of rational design and underlying antitumor therapeutic mechanisms of mammalian cells ...
Xiaodan Wei+10 more
wiley +1 more source
Timing of Anticoagulation Resumption in a Patient With Mechanical Heart Valves and Spontaneous Subdural Hematomas: A Case Report. [PDF]
Baby S, Lozonschi L.
europepmc +1 more source
Biodegradable Medical Implants: Reshaping Future Medical Practice
Biodegradable medical implants are transforming future healthcare by providing sustainable, biocompatible solutions that eliminate secondary removal procedures, enhancing patients’ physical and psychological comfort, and reducing economic burdens.
Bo Xia+4 more
wiley +1 more source
Improving the safety of heparin usage by standardisation of practice. [PDF]
Lui PL+7 more
europepmc +1 more source
The microbiota‐derived metabolite phenylacetylglutamine (PAGln) is elevated in type 2 diabetes and tightly associated with poor healing in both diabetic and non‐diabetic human patients. PAGln promotes mouse inflammation and impairs healing through a transmissible β2‐adrenergic receptor–mediated trained‐immunity loop.
Lu Huang+12 more
wiley +1 more source
Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor. [PDF]
Ciura K+5 more
europepmc +1 more source